Regulatory News In Brief

Sentinel Initiative workshop set for Jan. 31. Trade group offers tips on communicating about phthalates in medical devices.

The Fifth Annual Sentinel Initiative Public Workshop will take place Jan. 31 in Washington, D.C. Participants will hear an update on FDA’s Sentinel Initiative, which aims to improve the agency's ability to track the safety of medical products after they reach the market. Medical devices were added to the Sentinel Initiative with this year's passage of the FDA Safety and Innovation Act. (See Also see "Final FDA Bill: Device Provisions" - Medtech Insight, 25 June, 2012..) Attendees will also discuss findings from Mini-Sentinel protocol-based evaluations; current and future collaborations and initiative expansions; and stakeholder feedback on Mini-Sentinel as a tool for evaluating drug safety issues that require regulatory actions. The one-day workshop will be hosted by the Brookings Institution's Engelberg Center for Health Care Reform. Registration is required.

SPI, a plastics industry trade association, released a white paper Dec.11 on marketing claims related to phthalates in medical devices....

Welcome to Medtech Insight

Create an account to read this article

More from Regulation

Burden Is Too Heavy For Medtechs To Go It Alone On Complex Medtech AI Projects

 

Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By 

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

More from Policy & Regulation

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By 

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.